Key result
Confirmed HFpEF is linked to obesity, frailty, and walking 65 m less than those without.
Why the study?
Many patients with HFpEF remain undiagnosed and UK general practice registers rarely record HF subtype, yet management improvements depend on better primary care identification and characterisation.
Cross-Sectional (n=152)
Yes
Absolute Event Rate: 273% vs 338%
p-value: p=0.007
Patients with confirmed HFpEF in primary care exhibit high rates of multimorbidity, frailty, and polypharmacy, highlighting the need for comprehensive comorbidity management.
Supports integrated frailty and obesity management in primary care HFpEF; extends prior data but leaves causal and interventional questions open.
BACKGROUND: Many patients with heart failure with preserved ejection fraction (HFpEF) are undiagnosed, and UK general practice registers do not typically record heart failure (HF) subtype. Improvements in management of HFpEF is dependent on improved identification and characterisation of patients in primary care. AIM: To describe a cohort of patients recruited from primary care with suspected HFpEF and compare patients in whom HFpEF was confirmed and refuted. DESIGN & SETTING: Baseline data from a longitudinal cohort study of patients with suspected HFpEF recruited from primary care in two areas of England. METHOD: A screening algorithm and review were used to find patients on HF registers without a record of reduced ejection fraction (EF). Baseline evaluation included cardiac, mental and physical function, clinical characteristics, and patient reported outcomes. Confirmation of HFpEF was clinically adjudicated by a cardiologist. RESULTS: In total, 93 (61%) of 152 patients were confirmed HFpEF. The mean age of patients with HFpEF was 79 years, 46% were female, 80% had hypertension, and 37% took ≥10 medications. Patients with HFpEF were more likely to be obese, pre-frail or frail, report more dyspnoea and fatigue, were more functionally impaired, and less active than patients in whom HFpEF was refuted. Few had attended cardiac rehabilitation. CONCLUSION: Patients with confirmed HFpEF had frequent multimorbidity, functional impairment, frailty, and polypharmacy. Although comorbid conditions were similar between people with and without HFpEF, the former had more obesity, symptoms, and worse physical function. These findings highlight the potential to optimise wellbeing through comorbidity management, medication rationalisation, rehabilitation, and supported self-management.
No takes yet. Share an insight, caveat, or question.
A 2021 study conducted a cross-sectional in Heart failure with preserved ejection fraction (HFpEF) (n=152). Heart failure with preserved ejection fraction (HFpEF) vs. Non-HFpEF was evaluated on 6-minute walk distance (meters) (p=0.007). Patients with confirmed HFpEF in primary care were significantly more likely to be obese, frail, and functionally impaired, walking 65 m less on the 6-minute walk test than those without HFpEF.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: